Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
13.8M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
5.61M
-
Shares change
-
-124K
-
Total reported value, excl. options
-
$31.5M
-
Value change
-
-$742K
-
Put/Call ratio
-
2.06
-
Number of buys
-
7
-
Number of sells
-
-12
-
Price
-
$5.62
Significant Holders of CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) as of Q4 2023
32 filings reported holding CSBR - CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share as of Q4 2023.
CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.61M shares
of 13.8M outstanding shares and own 40.55% of the company stock.
Largest 10 shareholders include Battery Management Corp. (2.42M shares), NEA Management Company, LLC (1.71M shares), TOCQUEVILLE ASSET MANAGEMENT L.P. (685K shares), RENAISSANCE TECHNOLOGIES LLC (125K shares), BlackRock Inc. (116K shares), VANGUARD GROUP INC (82.8K shares), ESSEX INVESTMENT MANAGEMENT CO LLC (77.2K shares), AMERIPRISE FINANCIAL INC (75K shares), GEODE CAPITAL MANAGEMENT, LLC (61.3K shares), and NORTHERN TRUST CORP (44.9K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.